Home/Hedge Fund Intelligence/Spyre Therapeutics, Inc.
Nasdaq: SYREStockForm 13F30 Jun 2026

Hedge funds that hold Spyre Therapeutics, Inc. New Nasdaq: SYRE

New · CUSIP 00773J202 · who reports it, how much, and how much it matters to them

43 of the 720 hedge fund managers we track reported shares of Spyre Therapeutics, Inc. (Nasdaq: SYRE) on Form 13F for 30 June 2026. Between them they reported USD 1.4bn. The largest position belongs to Perceptive Advisors, at USD 383m.

Managers reporting it43of 720 we track
Value they reportUSD 1.4bnshares only, 30 Jun 2026
Funds they run593with a file on PPLI.com
Largest positionUSD 383mPerceptive Advisors
Typical weight0.1%median share of a manager's book
Heaviest weight5.8%Perceptive Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

43 managers, USD 1.4bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Spyre Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Perceptive Advisors6 funds on PPLI.comUSD 383m5.8%
2RTW Investments2 funds on PPLI.comUSD 377m3.2%
3Adage Capital Management1 fund on PPLI.comUSD 153m0.2%
4Holocene Advisors2 funds on PPLI.comUSD 90m0.2%
5Marshall Wace LLP84 funds on PPLI.comUSD 88m0.1%
6Polar Capital LLP26 funds on PPLI.comUSD 88m0.2%
7Braidwell12 funds on PPLI.comUSD 78m2.9%
8Samlyn Capital8 funds on PPLI.comUSD 36m0.6%
9Cormorant Asset Management1 fund on PPLI.comUSD 20m1.0%
10Millennium Management6 funds on PPLI.comUSD 17m0.0%
11Orbimed Advisors1 fund on PPLI.comUSD 17m0.3%
12Balyasny Asset Management25 funds on PPLI.comUSD 13m0.0%
13Squarepoint Ops7 funds on PPLI.comUSD 12m0.0%
14Armistice Capital1 fund on PPLI.comUSD 12m0.1%
15Citadel Advisors32 funds on PPLI.comUSD 9.2m0.0%
16Boxer Capital Management1 fund on PPLI.comUSD 8.9m0.7%
17HighVista Strategies27 funds on PPLI.comUSD 6.9m1.6%
18Hudson Bay Capital Management8 funds on PPLI.comUSD 5.2m0.0%
19Cinctive Capital Management5 funds on PPLI.comUSD 4.3m0.2%
20PFM Health Sciences3 funds on PPLI.comUSD 4.1m0.4%
21Rock Springs Capital Management2 funds on PPLI.comUSD 3.8m0.2%
22Engineers Gate Manager1 fund on PPLI.comUSD 3.4m0.0%
23D. E. Shaw & Co.15 funds on PPLI.comUSD 2.3m0.0%
24Aquatic Capital Management3 funds on PPLI.comUSD 2.2m0.1%
25Freestone Grove Partners1 fund on PPLI.comUSD 2m0.0%
26Schonfeld Strategic Advisors30 funds on PPLI.comUSD 1.7m0.0%
27Neo Ivy Capital Management1 fund on PPLI.comUSD 1.3m0.3%
28Two Sigma Investments35 funds on PPLI.comUSD 1.1m0.0%
29Atom Investors1 fund on PPLI.comUSD 1.1m0.1%
30Global Endowment Management90 funds on PPLI.comUSD 1.1m0.1%
31Diametric Capital2 funds on PPLI.comUSD 888,0000.1%
32Persistent Asset Partners10 funds on PPLI.comUSD 778,0000.2%
33Brevan Howard Capital Management39 funds on PPLI.comUSD 736,0000.0%
34Boothbay Fund Management2 funds on PPLI.comUSD 573,0000.0%
35Dark Forest Capital Management2 funds on PPLI.comUSD 461,0000.0%
36Wexford Capital8 funds on PPLI.comUSD 355,0000.0%
37Artia Global Partners1 fund on PPLI.comUSD 355,0000.1%
38Landscape Capital Management4 funds on PPLI.comUSD 344,0000.0%
39Tudor Investment Corporation10 funds on PPLI.comUSD 235,0000.0%
40CIBC Asset Management69 funds on PPLI.comUSD 216,0000.0%
41Bayforest Capital1 fund on PPLI.comUSD 205,0000.2%
42Fulcrum Asset Management LLP7 funds on PPLI.comUSD 191,0000.0%
43The Quarry1 fund on PPLI.comUSD 1780.0%
Next: where it matters most
Where it matters most

For Perceptive Advisors it is 5.8% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Perceptive AdvisorsUSD 383m5.8%
2RTW InvestmentsUSD 377m3.2%
3BraidwellUSD 78m2.9%
4HighVista StrategiesUSD 6.9m1.6%
5Cormorant Asset ManagementUSD 20m1.0%
6Boxer Capital ManagementUSD 8.9m0.7%
7Samlyn CapitalUSD 36m0.6%
8PFM Health SciencesUSD 4.1m0.4%
9Orbimed AdvisorsUSD 17m0.3%
10Neo Ivy Capital ManagementUSD 1.3m0.3%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Spyre Therapeutics, Inc.

What is the ticker symbol of Spyre Therapeutics, Inc.?

Spyre Therapeutics, Inc. trades under the symbol SYRE on the Nasdaq. Its CUSIP, the code used on Form 13F, is 00773J202.

Which hedge funds own Spyre Therapeutics, Inc. (Nasdaq: SYRE)?

43 of the 720 hedge fund managers PPLI.com tracks reported Spyre Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Perceptive Advisors (USD 383m), RTW Investments (USD 377m), Adage Capital Management (USD 153m), Holocene Advisors (USD 90m) and Marshall Wace LLP (USD 88m).

How many hedge funds hold Spyre Therapeutics, Inc.?

43 managers in our coverage reported it, and between them they run 593 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Spyre Therapeutics, Inc.?

Perceptive Advisors, where the position was 5.8% of the reported 13F book at 30 June 2026.

Does this show who is short Spyre Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Spyre Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.